Peculiarities of intensive care for pregnant and postpartum women with severe course of coronavirus disease (COVID-19)


  • N.V. Matolinets Danylo Halytsky Lviv National Medical University, Lviv, Ukraine; Municipal Non-Profit Enterprise “Lviv Clinical Emergency Care Hospital”, Lviv, Ukraine
  • O.O. Samchuk Municipal Non-Profit Enterprise “Lviv Clinical Emergency Care Hospital”, Lviv, Ukraine
  • S.I. Hlukhovska Danylo Halytsky Lviv National Medical University, Lviv, Ukraine; Municipal Non-Profit Enterprise “Lviv Clinical Emergency Care Hospital”, Lviv, Ukraine
  • K.Z. Zhyvitska Danylo Halytsky Lviv National Medical University, Lviv, Ukraine; Municipal Non-Profit Enterprise “Lviv Clinical Emergency Care Hospital”, Lviv, Ukraine



COVID-19, postpartum women, intensive care


Background. Coronavirus disease (COVID-19) is the biggest challenge the whole modern world has faced. Physicians and scientists are trying to find a solution to this problem. That is why many guidelines for the management of patients with ­COVID-19 have been created recently and they are constantly updating because of new results of the latest studies. But it is noticeable that there is a lack of protocols for certain special groups of the population the management of which differs from the treatment of the general population. Such groups include children, pregnant and postpartum women, the elderly, and patients who need surgery. The purpose of our study is to evaluate the management of pregnant and postpartum women in the Municipal Non-Profit Enterprise “Lviv Clinical Emergency Care Hospital”. Materials and methods. From September 2020, at the premises of the Municipal Non-Profit Enterprise “Lviv Clinical Emergency Care Hospital”, treatment has been carried out for pregnant and postpartum women with ­
COVID-19; three case reports are presented. Results. Unfortunately, the treatment does not always lead to positive outcomes, sometimes it can be fatal, as the course is often accompanied by bacterial complications on the background of immunosuppression. However, it was found that the best treatment regimen is still a combination of antibiotics, anticoagulants and hormones and excludes the widespread use of antiviral or antimalarial drugs. Continuous monitoring of vital functions and assessment of liver, kidney, and heart function is essential to prevent complications or detect them at an early stage. Conclusions. During treatment of pregnant women in the intensive care units, it is important to choose the right empirical therapy, think about delivery done in time and oxygen therapy, based on theoretical and practical principles of ventilation.


WHO Coronavirus Disease (COVID-19) Dashboard, Available from:

Elflein J. Hospitalization among COVID-19 positive women, U.S. 2020, by age and pregnancy status. July 16, 2020.

Tan E.K., Tan E.L. Alterations in physiology and anatomy during pregnancy. Best. Pract. Res. Clin. Obstet Gynaecol. 2013. 27. 791-802.

Sascha Ellington, Penelope Strid, Van T. Tong, Kate Woodworth, Romeo R. Galang, Laura D. Zambrano, John Nahabedian, Kayla Anderson, Suzanne M. Gilboa. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22 — June 7, 2020, Weekly/June 26, 2020/69(25). 769-775.

Сoronavirus (COVID-19) infection in pregnancy. Royal college of obstetricians & gynaecologists [Internet] [cited 24.07.2020]. Available from: [2, pp. 21-23, 33-38].

Sonja A. Rasmussen, John C. Smulian, John A. Lednicky, Tony S. Wen, Denise J. Jamieson. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am. J. Obstet Gynecol. 2020 May. 222(5). 415-426. doi: 10.1016/j.ajog.2020.02.017.

Vincenzo Berghella, Brenna Hughes. Coronavirus disease 2019 (COVID-19). Pregnancy issues 8. Marian Knight, Kathryn Bunch, Nicola Vousden, Erward Morris, Nigel Simpson, Chris Gale, Patrick O’Brien, Maria Quigley, Peter Brocklehurst, Jennifer J. Kurinczuk. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020. 369. m2107. doi: 10.1136/bmj.m2107.

Huijun Chen, Juanjuan Guo, Chen Wang, Fan Luo, Xue-chen Yu, Wei Zhang, Jiafu Li, Dongchi Zhao, Dan Xu, Qing Gong, Jing Liao, Huixia Yang, Wei Hou, Yuanzhen Zhang. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020 Mar 7. doi: 10.1016/S0140-6736(20)30360-3.

Alessandro Favilli, Marta Mattei Gentili, Francesca Raspa, Irene Giardina, Fabio Parazzini, Amerigo Vitagliano, Anna V. Borisova, and Sandro Gerli. Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review. J. Matern. Fetal. Neonatal. Med. 2020. 1-14. doi: 10.1080/14767058.2020.1774875.

Guidance for Management of Pregnant Women in COVID-19 PandemicICMR. National Institute for Research in Reproductive Health Jehangir Merwanji Street, Parel, Mumbai -400 012.

Balakrishnan Ashokka, May-Han Loh, Cher Heng Tan, Lin Lin Su, Barnaby Edward Young, David Chien Lye, Arijit Biswas, Sebastian E. Illanes and Mahesh Choolani. Care of the pregnant woman with coronavirus disease 2019 in labor and delivery: anesthesia, emergency cesarean delivery, differential diagnosis in the acutely ill parturient, care of the newborn, and protection of the healthcare personnel. Am. J. Obstet. Gynecol. 2020 Jul. 223(1). 66-74.e3. doi: 10.1016/j.ajog.2020.04.005.

Juan J., Gil M.M., Rong Z., Zhang Y., Yang H., Poon L.C. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020 Jul. 56(1). 15-27. doi: 10.1002/uog.22088. PMID: 32430957. PMCID: PMC7276742.





Original Researches